This suggests that glioma initiation may occur prior to biallelic NF1 inactivation in some patients, with the somatic events targeting the remaining wildtype NF1 allele occurring within different tumor subclones later during gliomagenesis. The gene discussed is NF1; the disease is neoplasm.